Chinese General Practice ›› 2022, Vol. 25 ›› Issue (33): 4185-4190.DOI: 10.12114/j.issn.1007-9572.2022.0333
Special Issue: 睡眠问题专题研究
• Article • Previous Articles Next Articles
Received:
2022-07-11
Revised:
2022-07-21
Published:
2022-11-20
Online:
2022-09-08
Contact:
DING Ning
About author:
通讯作者:
丁宁
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0333
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 男性 〔n(%)〕 | BMI 〔M(P25,P75),kg/m2〕 | ESS评分〔M(P25,P75),分〕 |
---|---|---|---|---|---|
少发心律失常组 | 18 | 49(36,59) | 14(77.8) | 28.0(26.4,32.6) | 13.0(7.0,16.0) |
多发心律失常组 | 18 | 60(44,73) | 18(100.0) | 26.3(23.5,27.9) | 14.0(6.0,18.0) |
Z值 | -1.615 | — | -2.199 | -0.444 | |
P值 | 0.106 | 0.104 | 0.028 | 0.657 | |
组别 | AHI 〔M(P25,P75),次/h〕 | 平均SpO2 〔M(P25,P75),%〕 | 最低SpO2 〔M(P25,P75),%〕 | T90% 〔M(P25,P75),%〕 | |
少发心律失常组 | 15.8(9.6,37.1) | 93.0(92.0,95.0) | 80.0(69.0,84.0) | 4.5(1.0,17.5) | |
多发心律失常组 | 20.1(9.4,46.3) | 93.0(91.0,95.0) | 78.0(68.0,86.0) | 11.0(2.0,33.0) | |
Z值 | -0.506 | -0.830 | -0.269 | -0.888 | |
P值 | 0.613 | 0.424 | 0.788 | 0.375 | |
组别 | ∆S 〔M(P25,P75)〕 | ODR 〔M(P25,P75)〕 | ∆HR 〔M(P25,P75)〕 | HRFR 〔M(P25,P75)〕 | |
少发心律失常组 | 15.0(10.0,20.0) | 0.5(0.3,0.7) | 9.0(5.0,15.0) | 0.6(0.5,1.1) | |
多发心律失常组 | 14.0(9.0,21.0) | 1.0(0.8,1.2) | 14.0(12.0,18.0) | 1.3(0.9,1.7) | |
Z值 | -0.237 | -4.430 | -1.915 | -2.595 | |
P值 | 0.812 | <0.001 | 0.055 | 0.009 |
Table 1 Parameters comparison between low and high incidence of arrhythmia groups
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 男性 〔n(%)〕 | BMI 〔M(P25,P75),kg/m2〕 | ESS评分〔M(P25,P75),分〕 |
---|---|---|---|---|---|
少发心律失常组 | 18 | 49(36,59) | 14(77.8) | 28.0(26.4,32.6) | 13.0(7.0,16.0) |
多发心律失常组 | 18 | 60(44,73) | 18(100.0) | 26.3(23.5,27.9) | 14.0(6.0,18.0) |
Z值 | -1.615 | — | -2.199 | -0.444 | |
P值 | 0.106 | 0.104 | 0.028 | 0.657 | |
组别 | AHI 〔M(P25,P75),次/h〕 | 平均SpO2 〔M(P25,P75),%〕 | 最低SpO2 〔M(P25,P75),%〕 | T90% 〔M(P25,P75),%〕 | |
少发心律失常组 | 15.8(9.6,37.1) | 93.0(92.0,95.0) | 80.0(69.0,84.0) | 4.5(1.0,17.5) | |
多发心律失常组 | 20.1(9.4,46.3) | 93.0(91.0,95.0) | 78.0(68.0,86.0) | 11.0(2.0,33.0) | |
Z值 | -0.506 | -0.830 | -0.269 | -0.888 | |
P值 | 0.613 | 0.424 | 0.788 | 0.375 | |
组别 | ∆S 〔M(P25,P75)〕 | ODR 〔M(P25,P75)〕 | ∆HR 〔M(P25,P75)〕 | HRFR 〔M(P25,P75)〕 | |
少发心律失常组 | 15.0(10.0,20.0) | 0.5(0.3,0.7) | 9.0(5.0,15.0) | 0.6(0.5,1.1) | |
多发心律失常组 | 14.0(9.0,21.0) | 1.0(0.8,1.2) | 14.0(12.0,18.0) | 1.3(0.9,1.7) | |
Z值 | -0.237 | -4.430 | -1.915 | -2.595 | |
P值 | 0.812 | <0.001 | 0.055 | 0.009 |
项目 | 年龄 | BMI | 高血压 | ESS | AHI | 平均SpO2 | 最低SpO2 | T90% | ∆S | ODR | ∆HR | HRFR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs值 | 0.472 | -0.390 | -0.005 | -0.044 | 0.025 | -0.043 | 0.046 | 0.105 | -0.050 | 0.719 | 0.360 | 0.393 |
P值 | 0.004 | 0.019 | 0.975 | 0.799 | 0.887 | 0.801 | 0.789 | 0.540 | 0.771 | <0.001 | 0.031 | 0.018 |
Table 2 The correlations between total number of arrhythmia events and other parameters
项目 | 年龄 | BMI | 高血压 | ESS | AHI | 平均SpO2 | 最低SpO2 | T90% | ∆S | ODR | ∆HR | HRFR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
rs值 | 0.472 | -0.390 | -0.005 | -0.044 | 0.025 | -0.043 | 0.046 | 0.105 | -0.050 | 0.719 | 0.360 | 0.393 |
P值 | 0.004 | 0.019 | 0.975 | 0.799 | 0.887 | 0.801 | 0.789 | 0.540 | 0.771 | <0.001 | 0.031 | 0.018 |
项目 | 赋值 |
---|---|
性别 | 女=1,男=2 |
年龄 | 年龄<55岁=1,年龄≥55岁=2 |
BMI | BMI<27 kg/m2=1,BMI≥27 kg/m2=2 |
高血压 | 无=1,有=2 |
AHI | AHI<15次/h=1,AHI≥15次/h=2 |
平均SpO2 | 平均SpO2>90%=1,平均SpO2≤90%=2 |
最低SpO2 | 最低SpO2>80%=1,最低SpO2≤80%=2 |
T90% | T90%<10%=1,T90%≥10%=2 |
∆S | ∆S<15=1,∆S≥15=2 |
ODR | ODR<0.8%=1,ODR≥0.8%=2 |
∆HR | ∆HR<13=1,∆HR≥13=2 |
HRFR | HRFR<0.9%=1,HRFR≥0.9%=2 |
Table 3 Assignment for independent factors possibly influencing the developing of arrhythmia
项目 | 赋值 |
---|---|
性别 | 女=1,男=2 |
年龄 | 年龄<55岁=1,年龄≥55岁=2 |
BMI | BMI<27 kg/m2=1,BMI≥27 kg/m2=2 |
高血压 | 无=1,有=2 |
AHI | AHI<15次/h=1,AHI≥15次/h=2 |
平均SpO2 | 平均SpO2>90%=1,平均SpO2≤90%=2 |
最低SpO2 | 最低SpO2>80%=1,最低SpO2≤80%=2 |
T90% | T90%<10%=1,T90%≥10%=2 |
∆S | ∆S<15=1,∆S≥15=2 |
ODR | ODR<0.8%=1,ODR≥0.8%=2 |
∆HR | ∆HR<13=1,∆HR≥13=2 |
HRFR | HRFR<0.9%=1,HRFR≥0.9%=2 |
变量 | SE | β | P值 | OR值 | 95%CI |
---|---|---|---|---|---|
ODR(以<0. 8为参考) | 1. 376 | 4. 355 | 0. 002 | 77. 849 | (5. 250,1 154. 301) |
HRFR(以<0. 9为参考) | 1. 204 | 2. 301 | 0. 050 | 9. 981 | (1.000,105. 600) |
常量 | 3. 126 | -9. 367 | 0. 003 | 0 | — |
Table 4 Multivariate Logistic regression analysis of the relationship between arrhythmia events and other parameters
变量 | SE | β | P值 | OR值 | 95%CI |
---|---|---|---|---|---|
ODR(以<0. 8为参考) | 1. 376 | 4. 355 | 0. 002 | 77. 849 | (5. 250,1 154. 301) |
HRFR(以<0. 9为参考) | 1. 204 | 2. 301 | 0. 050 | 9. 981 | (1.000,105. 600) |
常量 | 3. 126 | -9. 367 | 0. 003 | 0 | — |
[1] |
张建琴.南方医院睡眠中心及心内科住院病人阻塞性睡眠呼吸暂停低通气综合征流行病学调查及其与心血管病关系研究[D]. 广州:南方医科大学,2017.
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J]. 中华结核和呼吸杂志,2012,1:9-12. DOI:10.3760/cma.j.issn.1001-0939.2012.01.007.
|
[9] |
|
[10] |
|
[11] |
王君,郑小兵,张希龙,等. 心血管病患者中阻塞性睡眠呼吸暂停的临床特征及危险因素分析[J]. 临床肺科杂志,2022,27(6):817-821.
|
[12] |
王晓舟,殷西亮,王晓娟,等. 睡眠呼吸暂停综合征对冠心病患者心律失常发生的影响[J]. 数理医药学杂志,2011,24(6):682-684. DOI:10.3969/j.issn.1004-4337.2011.06.017.
|
[13] |
黄芃菲,叶岚. 阻塞性睡眠呼吸暂停低通气综合征与心律失常的相关性[J]. 心血管病学进展,2018,39(6):923-926. DOI:10.16806/j.cnki.issn.1004-3934.2018.06.014.
|
[14] |
刘新兵,周明成,李毅刚. 阻塞性睡眠呼吸暂停综合征和心血管事件相关性及其机制探讨[J]. 心血管康复医学杂志,2012,21(3):335-337. DOI:10.3969/j.issn.1008-0074.2012.03.38.
|
[15] |
|
[16] |
朱凌霞,佟光明,尤涛,等. 睡眠呼吸暂停低通气综合征患者QT离散度及心律失常临床研究[J]. 中国全科医学,2013,16(30):3551-3553. DOI:10.3969/j.issn.1007-9572.2013.28.082.
|
[17] |
郭辉,李学文. 阻塞性睡眠呼吸暂停低通气综合征患者心律失常的发生及相关因素的研究[J]. 中国心脏起搏与心电生理杂志,2015,29(5):462-465. DOI:10.13333/j.cnki.cjcpe.2015.05.008.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[1] | CHU Xiaojing, LI Jun, FU Yanqin, LIU Danqing, LIU Aiping, ZHANG Yuanyuan. Effect of Human Body Composition and Serum Biochemical Indicators on the Accuracy of Flash Glucose Monitoring System [J]. Chinese General Practice, 2023, 26(35): 4433-4438. |
[2] | XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue. Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis [J]. Chinese General Practice, 2023, 26(35): 4394-4403. |
[3] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[4] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[5] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[6] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[7] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[8] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[9] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[10] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[11] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[12] | WANG Yu, CHEN Yan, HAN Yuanyuan, XU Qing, CHEN Shengyue, LYU Zhibo, LU Chuan, ZHENG Mingxin, ZHAO Xin. Platelet-lymphocyte Ratio Predicts In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(33): 4137-4142. |
[13] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[14] | GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050. |
[15] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||